BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,570.00
-240.00 (-3.52%)
At close: Mar 26, 2025, 3:30 PM KST
-40.27%
Market Cap 31.80B
Revenue n/a
Net Income n/a
Shares Out 4.80M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend 400.00 (6.09%)
Ex-Dividend Date Dec 27, 2024
Volume 824,256
Average Volume 453,995
Open 6,860.00
Previous Close 6,810.00
Day's Range 6,450.00 - 7,530.00
52-Week Range 4,965.00 - 11,580.00
Beta 0.89
RSI 60.71
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.